151 related articles for article (PubMed ID: 17322294)
1. Crystal structure of the third extracellular domain of CD5 reveals the fold of a group B scavenger cysteine-rich receptor domain.
Rodamilans B; Muñoz IG; Bragado-Nilsson E; Sarrias MR; Padilla O; Blanco FJ; Lozano F; Montoya G
J Biol Chem; 2007 Apr; 282(17):12669-77. PubMed ID: 17322294
[TBL] [Abstract][Full Text] [Related]
2. The Scavenger Receptor Cysteine-Rich (SRCR) domain: an ancient and highly conserved protein module of the innate immune system.
Sarrias MR; Grønlund J; Padilla O; Madsen J; Holmskov U; Lozano F
Crit Rev Immunol; 2004; 24(1):1-37. PubMed ID: 14995912
[TBL] [Abstract][Full Text] [Related]
3. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily.
Hohenester E; Sasaki T; Timpl R
Nat Struct Biol; 1999 Mar; 6(3):228-32. PubMed ID: 10074941
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Scavenger Receptor Cysteine-Rich Domain Binding to Bacteria.
Telfer JC; Hsu H; Tyner MD; Le Page L
Methods Mol Biol; 2022; 2421():141-150. PubMed ID: 34870817
[TBL] [Abstract][Full Text] [Related]
6. Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction.
Chappell PE; Garner LI; Yan J; Metcalfe C; Hatherley D; Johnson S; Robinson CV; Lea SM; Brown MH
Structure; 2015 Aug; 23(8):1426-1436. PubMed ID: 26146185
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the CD6 ligand binding domain.
Skonier JE; Bodian DL; Emswiler J; Bowen MA; Aruffo A; Bajorath J
Protein Eng; 1997 Aug; 10(8):943-7. PubMed ID: 9415444
[TBL] [Abstract][Full Text] [Related]
8. CD6-ligand interactions: a paradigm for SRCR domain function?
Aruffo A; Bowen MA; Patel DD; Haynes BF; Starling GC; Gebe JA; Bajorath J
Immunol Today; 1997 Oct; 18(10):498-504. PubMed ID: 9357143
[TBL] [Abstract][Full Text] [Related]
9. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
[TBL] [Abstract][Full Text] [Related]
10. Partial cDNA sequences of bovine CD72 and CD166/ALCAM, ligands for SRCR-family accessory molecules CD5 and CD6.
Rogers AN; Welte S; Black SJ; Baldwin CL
Vet Immunol Immunopathol; 2002 Mar; 85(3-4):233-9. PubMed ID: 11943324
[TBL] [Abstract][Full Text] [Related]
11. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
[TBL] [Abstract][Full Text] [Related]
12. Genomic organization of the human CD5 gene.
Padilla O; Calvo J; Vilà JM; Arman M; Gimferrer I; Places L; Arias MT; Pujana MA; Vives J; Lozano F
Immunogenetics; 2000 Oct; 51(12):993-1001. PubMed ID: 11061284
[TBL] [Abstract][Full Text] [Related]
13. CD6, a Rheostat-Type Signalosome That Tunes T Cell Activation.
Gonçalves CM; Henriques SN; Santos RF; Carmo AM
Front Immunol; 2018; 9():2994. PubMed ID: 30619347
[TBL] [Abstract][Full Text] [Related]
14. The accessory molecules CD5 and CD6 associate on the membrane of lymphoid T cells.
Gimferrer I; Farnós M; Calvo M; Mittelbrunn M; Enrich C; Sánchez-Madrid F; Vives J; Lozano F
J Biol Chem; 2003 Mar; 278(10):8564-71. PubMed ID: 12473675
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis of the CD5 antigen--expression, disulphide bond analysis and physical characterisation of CD5 scavenger receptor superfamily domain 1.
McAlister MS; Brown MH; Willis AC; Rudd PM; Harvey DJ; Aplin R; Shotton DM; Dwek RA; Barclay AN; Driscoll PC
Eur J Biochem; 1998 Oct; 257(1):131-41. PubMed ID: 9799111
[TBL] [Abstract][Full Text] [Related]
16. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand.
Calvo J; Places L; Padilla O; Vilà JM; Vives J; Bowen MA; Lozano F
Eur J Immunol; 1999 Jul; 29(7):2119-29. PubMed ID: 10427974
[TBL] [Abstract][Full Text] [Related]
17. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.
Bowen MA; Aruffo AA; Bajorath J
Proteins; 2000 Aug; 40(3):420-8. PubMed ID: 10861932
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.
Velasco-de Andrés M; Casadó-Llombart S; Català C; Leyton-Pereira A; Lozano F; Aranda F
Cells; 2020 Dec; 9(12):. PubMed ID: 33287301
[TBL] [Abstract][Full Text] [Related]
19. Identification of residues in CD6 which are critical for ligand binding.
Bodian DL; Skonier JE; Bowen MA; Neubauer M; Siadak AW; Aruffo A; Bajorath J
Biochemistry; 1997 Mar; 36(9):2637-41. PubMed ID: 9054570
[TBL] [Abstract][Full Text] [Related]
20. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.
Zimmerman AW; Joosten B; Torensma R; Parnes JR; van Leeuwen FN; Figdor CG
Blood; 2006 Apr; 107(8):3212-20. PubMed ID: 16352806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
